Low SFRP4 expression predominated in higher astrocytoma grades (3 and 4) (p = 0.002) where 60% of grade 3 astrocytomas and 86.7% of glioblastomas showed weak or lack of expression. This evidence concerns the gene SFRP4 and astrocytoma (excluding glioblastoma).